Research on TILs is rapidly advancing. Scientists are exploring ways to enhance the efficacy of TIL therapy, such as genetically modifying these cells to improve their ability to target tumors. Additionally, advances in understanding the tumor microenvironment are helping researchers develop strategies to overcome immunosuppression, making TILs more effective in cancer treatment.
